+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point of Care (PoC) Molecular Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026

  • ID: 5147629
  • Report
  • September 2020
  • Region: Global
  • 150 pages
  • OG Analysis
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abaxis
  • Abbott Laboratories
  • Alere Inc
  • Bayer Healthcare
  • Biomerieux
  • Bio-Rad Laboratories
  • MORE
The study predicts the short term and long term trends that can shape the future of the Point of Care (PoC) Molecular Diagnostics market including the COVID-19 pandemic implications for the Point of Care (PoC) Molecular Diagnostics industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Point of Care (PoC) Molecular Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Point of Care (PoC) Molecular Diagnostics Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Point of Care (PoC) Molecular Diagnostics market forecast and Point of Care (PoC) Molecular Diagnostics market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020-2026 as the forecast period. The research was based on the findings of an expert team of analysts analyzing the Point of Care (PoC) Molecular Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Point of Care (PoC) Molecular Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening the Point of Care (PoC) Molecular Diagnostics market share in developed countries.

Scope of the Research

Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 by application including
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Others

Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 by technology including
PCR Based
Genetic Sequencing Based
Hybridization Based
Microarray Based

Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 by End User including
Laboratories
Hospitals
Homecare
Others

Top Companies Operating in the Point of Care (PoC) Molecular Diagnostics market include Abaxis, Abbott Laboratories, Alere Inc, Bayer Healthcare, BioMerieux, Bio-Rad Laboratories, Dako, Danaher Corporation, Nipro Diagnostics, Nova Biomedical
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abaxis
  • Abbott Laboratories
  • Alere Inc
  • Bayer Healthcare
  • Biomerieux
  • Bio-Rad Laboratories
  • MORE
1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Point of Care (Poc) Molecular Diagnostics Market- Key Findings, 2020

3. Strategic Imperatives on Global Point of Care (Poc) Molecular Diagnostics Market
3.1 Covid-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End-user Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Point of Care (Poc) Molecular Diagnostics Companies

4. Global Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026 Outlook by Application
4.1 Infectious Diseases
4.2 Oncology
4.3 Hematology
4.4 Prenatal Testing
4.5 Endocrinology
4.6 Others

5. Global Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026 Outlook by Technology
5.1 Pcr Based
5.2 Genetic Sequencing Bassed
5.3 Hybridization Based
5.4 Microarray Based

6. Global Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026 Outlook by End-user
6.1 Laboratories
6.2 Hospitals
6.3 Homecare
6.4 Others

7 Asia-Pacific Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026
7.1 Leading Point of Care (Poc) Molecular Diagnostics Types Contributing to Asia-Pacific Market
7.2 Top Applications Contributing to Asia-Pacific Point of Care (Poc) Molecular Diagnostics
7.3 Top Countries Contributing to Asia-Pacific Point of Care (Poc) Molecular Diagnostics

8 Europe Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026
8.1 Leading Point of Care (Poc) Molecular Diagnostics Types Contributing to Europe Market
8.2 Top Applications Contributing to Europe Point of Care (Poc) Molecular Diagnostics
8.3 Top Countries Contributing to Europe Point of Care (Poc) Molecular Diagnostics

9 North America Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026
9.1 Leading Point of Care (Poc) Molecular Diagnostics Types Contributing to North America Market
9.2 Top Applications Contributing to North America Point of Care (Poc) Molecular Diagnostics
9.3 Top Countries Contributing to North America Point of Care (Poc) Molecular Diagnostics

10 South and Central America Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026
10.1 Leading Point of Care (Poc) Molecular Diagnostics Types Contributing to South and Central America Market
10.2 Top Applications Contributing to South and Central America Point of Care (Poc) Molecular Diagnostics
10.3 Top Countries Contributing to South and Central America Point of Care (Poc) Molecular Diagnostics

11 Middle East Africa Point of Care (Poc) Molecular Diagnostics Market Value Outlook to 2026
11.1 Leading Point of Care (Poc) Molecular Diagnostics Types Contributing to Middle East Africa Market
11.2 Top Applications Contributing to Middle East Africa Point of Care (Poc) Molecular Diagnostics
11.3 Top Countries Contributing to Middle East Africa Point of Care (Poc) Molecular Diagnostics

12 Business Profiles of Leading Companies
12.1 Business Description, SWOT and Financial Analysis of Companies in Point of Care (Poc) Molecular Diagnostics Market
12.2 Abaxis
12.3 Abbott Laboratories
12.4 Alere Inc
12.5 Bayer Healthcare
12.6 Biomerieux
12.7 Bio-Rad Laboratories
12.8 Dako
12.9 Danaher Corporation
12.10 Nipro Diagnostics
12.11 Nova Biomedical

13 Recent Industry Developments

14 Appendix
14.1 Analyst Expertise
14.2 Sources and Methodology
14.3 Contacts
Note: Product cover images may vary from those shown
3 of 4
  • Abaxis
  • Abbott Laboratories
  • Alere Inc
  • Bayer Healthcare
  • Biomerieux
  • Bio-Rad Laboratories
  • Dako
  • Danaher Corporation
  • Nipro Diagnostics
  • Nova Biomedical
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll